- What the Letters Stand For
- The College Behind the Credential
- What a Diplomate Is Expected to Know
- The Two-Phase Path to the Title
- Exam Format and Remote Delivery
- Fees and Registration Mechanics
- The Five-Year Eligibility Window
- Where Diplomates Work
- Sequencing Preparation Around the Domains
- Keeping the Acronym Straight
- Frequently Asked Questions
- DACVCP means Diplomate, American College of Veterinary Clinical Pharmacology, a veterinary specialty credential governed by the ACVCP.
- Earning the title requires passing both Phase I (200 multiple-choice questions) and Phase II (ten question groups worth 200 points).
- Phase II eligibility requires two peer-reviewed papers accepted or published by February 1 of the examination year.
- Both phases must be passed within a five-year eligibility window; this is an exam window, not a renewal cycle.
What the Letters Stand For
DACVCP stands for Diplomate, American College of Veterinary Clinical Pharmacology. Each piece of the acronym carries meaning. "Diplomate" is the formal term for a veterinarian who has been certified by a specialty college. "American College of Veterinary Clinical Pharmacology" is the certifying organization, usually shortened to ACVCP. When you see the letters after a veterinarian's name, they signal that the person completed approved residency-level training in clinical pharmacology and passed a two-phase credentialing process administered by that college.
This page is about that specific credential. Other pharmacology-adjacent designations in other professions can look similar on a résumé, but the Diplomate credential discussed here belongs to the veterinary specialty college and is tied to veterinary drug science: how drugs behave in animals, why they fail, how to dose them, and how to evaluate them. If you want the short-form definitions, our companion pages cover what DACVCP stands for and what DACVCP is, while this article goes deeper into what the credential demands.
The College Behind the Credential
The ACVCP is the governing and administering body for the credential. It publishes the application timelines, fee schedules, residency pathways and examination pages that define how a candidate becomes a Diplomate. It also maintains a Maintenance of Certification committee that administers recertification for existing Diplomates.
A note on what is and is not publicly settled: historical bylaws text (approved June 2018) describes review of maintenance records every two years toward maintenance at ten years, but the complete legacy file could not be retrieved in the latest check, and the detailed committee page requires authorization. Current renewal hours, fees and intervals should therefore be confirmed directly with the college rather than assumed from older documents.
What a Diplomate Is Expected to Know
The title implies mastery of a broad pharmacology curriculum. The dated Phase I preparation headings run from basic science through organ-system pharmacology and drug classes. The Phase II examination page lists four subject categories. Together they form the 26 headings used on this site (a count of supplied headings, not an official combined domain count). For the full walkthrough, see our complete guide to all 26 DACVCP content areas.
Foundational science (legacy Phase I headings)
Domains 1-9: Principles of Drug Behavior
These headings cover how a molecule is built, how it moves, what it does, and why therapy goes wrong.
- Physiochemical characteristics of active pharmaceutical ingredients (the source spelling)
- Pharmacodynamics and drug movement
- Pharmacokinetics
- Factors impacting drug movement and/or drug response
- Routes of administration
- Dosing forms (and relevant drug delivery devices)
- Adverse events
- Causes for therapeutic failure
Organ systems and drug classes
Domains 10-22: Applied Pharmacology by System and Class
These headings apply the principles to body systems and therapeutic categories.
- Nervous system, renal, cardiovascular, gastrointestinal, reproduction, endocrine
- General and special senses
- Control of inflammation/immunomodulation
- Anticancer drugs and fluid therapy
- Anti-infectives
- Botanical/herbals
- Disinfectants/antiseptics
Phase II subject categories
Domains 23-26: The Four Phase II Categories
The current Phase II page names four categories. It does not publish current category percentages, so none are stated here.
- Therapeutics
- Pharmacokinetics and Therapeutic Drug Monitoring
- Experimental Design, Statistics and Analytical Methods
- Regulatory Pharmacology
Notice the shift: Phase I leans toward broad pharmacology knowledge, while Phase II pushes into applied therapeutics, quantitative reasoning, trial design and regulatory thinking. A Diplomate is expected to operate comfortably in both modes.
The Two-Phase Path to the Title
The complete credential requires both phases. They are sequential, and each has its own eligibility gate.
| Element | Phase I | Phase II |
|---|---|---|
| Prerequisite | Legally qualified to practice veterinary medicine; enrolled in or completed approved ACVCP residency training; two references | Completed approved training, Phase I pass, approved credentials, course documentation and transcripts, two qualifying papers |
| Exam structure | 200 multiple-choice questions in two 100-question sessions | Ten question groups worth 200 points across two 100-point sessions |
| Question styles | Multiple choice | Written responses, multiple choice, fill-in-the-blank and extended matching |
| Active exam time | Eight hours, excluding break | Eight hours under the ordinary schedule |
One caution: Phase II's 200 points are not a 200-question count. The ten groups mix question formats, and points are allocated across them. For the eligibility details behind each gate, see our DACVCP requirements guide.
The Phase II publication requirement
This is the feature that most distinguishes the credential from many other certifications. Phase II candidates must have two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research; the other may be original research or an eligible evidence-based systematic review or meta-analysis. First authorship is required on at least one paper. Neither paper may have been used for another specialty board, and publication must not predate the beginning of training by more than two years.
Exam Format and Remote Delivery
The published 2026 administration was delivered remotely using ExamSoft: Phase I on May 19 and Phase II on June 30. Those dates have passed, and a 2027 schedule was not verified, so check the college's Candidate Information page for the next cycle. For the date-and-deadline picture, see our DACVCP exam dates guide.
Practical delivery details from the published materials:
- Candidates supply a compatible Windows or Mac laptop running Examplify, with administrator privileges.
- Encrypted examinations are downloaded in advance and unlocked with a proctor password.
- Examination mode blocks internet access, files and other applications.
- Phase I ordinarily runs 08:00-12:00 and 14:00-18:00 local time, in two 100-question sessions.
- Advance practice examinations are available to rehearse the software and become familiar with question structure.
The dated 2026 notice takes precedence over generic phase-page references to a testing location or on-site practice, so do not assume an in-person site without confirming the current cycle.
Fees and Registration Mechanics
The published 2026 cycle lists these charges:
| Step | Published 2026 Amount |
|---|---|
| Phase I application | USD 75 |
| Phase I examination | USD 200 |
| Phase II credentials review | USD 250 |
| Phase II examination | USD 300 |
Two details deserve care. First, a separate residency-information page calls USD 75 a first-year candidate registration fee. The public pages do not establish whether that is the same charge as the Phase I application fee or an additional one, so do not assume either; ask the college. Second, retakes require the respective examination fee. The general fee page permits refunds only for extenuating circumstances accepted by the Board, while the phase pages describe examination fees as nonrefundable. For a fuller budget view, including costs beyond these published fees, see our DACVCP certification cost breakdown.
Deadlines on the Phase II side
Applications are ordinarily due October 1 before the examination year, with intent to sit due by February 1. The currently dated checklist covers October 1, 2025 and February 1, 2026. Because the paper-acceptance cutoff is also February 1, those two obligations land on the same date.
The Five-Year Eligibility Window
Both phases must be passed within a five-year eligibility period. The period begins with the first eligible examination year after Phase I approval. The issuer's own example: approval in December 2025 permits examinations from 2026 through 2030.
Key Takeaway
The five-year window is an examination eligibility limit, not credential renewal. Do not confuse it with maintenance of certification, which is a separate process administered by a dedicated committee after you become a Diplomate.
This window shapes strategy. Because Phase II depends on a Phase I pass, delays in passing Phase I or in assembling papers consume the same five-year clock.
Where Diplomates Work
The public materials do not publish a hiring survey, so employer distribution should not be quantified. Qualitatively, the skill set maps to settings where drug behavior, dosing evidence and regulatory knowledge matter:
- Academic veterinary programs: teaching pharmacology, supervising residents and running research programs.
- Clinical pharmacology services: supporting dosing, therapeutic drug monitoring and adverse event questions for clinicians.
- Industry: drug development, formulation and study design roles where pharmacokinetics and trial methods are central.
- Regulatory and government settings: roles touching regulatory pharmacology and product evaluation.
For career-oriented detail, see our pages on DACVCP jobs and DACVCP earnings, and for the bigger decision, whether the certification is worth it.
Sequencing Preparation Around the Domains
Generic study methods matter less here than domain order. Because the foundational headings (Domains 1-9) underpin everything else, they belong first. Pharmacokinetics and drug movement in particular recur across system chapters, so calculation fluency pays off repeatedly.
Principles first
- Physiochemical properties, drug movement and pharmacokinetics (Domains 1, 3, 4)
- Pharmacodynamics and factors altering response (Domains 2, 5)
Delivery and failure modes
- Routes of administration and dosing forms (Domains 6, 7)
- Adverse events and causes for therapeutic failure (Domains 8, 9)
Systems and classes
- Organ-system chapters (Domains 10-16)
- Inflammation, anticancer, fluids, anti-infectives, botanicals, antiseptics (Domains 17-22)
Applied and quantitative
- Therapeutics and therapeutic drug monitoring (Domains 23, 24)
- Experimental design, statistics and regulatory pharmacology (Domains 25, 26)
Treat this as a skeleton, not a prescription; your residency training and the current blueprint should refine it. For a full plan, use our DACVCP study guide, and for a condensed refresher, the DACVCP cheat sheet. When you want exam-style repetition, our practice test platform offers question drills to build speed with multiple-choice formats.
Preparing for the written-response style
Phase I is entirely multiple choice, but Phase II adds written responses and extended matching. Candidates who have only drilled recognition-style questions should practice composing short, structured answers: state the mechanism, justify the dose logic, name the monitoring plan and flag the adverse event risk. Because the Phase II format mixes question types across ten groups, versatility counts.
Keeping the Acronym Straight
Searching for "DACVCP meaning" can surface material about unrelated credentials that happen to share the same letters. Everything on this page refers only to the veterinary clinical pharmacology Diplomate credential from the ACVCP. If a source mentions a different certifying body, different fee schedule or a different exam structure, it is describing something else.
When verifying any claim, check it against the ACVCP's own pages: the Phase I and Phase II examination pages, Candidate Deadlines and Fees, Candidate Information and the Phase II Credentials Review. Related definition pages on this site include what DACVCP means, what DACVCP certification is and the credential overview. If you are weighing difficulty, see how hard the exam is; for scoring, note that a fixed numerical pass mark and current pass rate were not verified, which is covered on our passing score and pass rate pages.
DACVCP stands for Diplomate, American College of Veterinary Clinical Pharmacology. It identifies a veterinarian certified by the ACVCP in the specialty of veterinary clinical pharmacology.
Yes. The complete credential requires both Phase I and Phase II. Phase I is 200 multiple-choice questions; Phase II has ten question groups worth 200 points, using written responses, multiple choice, fill-in-the-blank and extended matching.
Candidates need two peer-reviewed papers accepted or published by February 1 of the examination year. At least one must be original veterinary clinical pharmacology research, and at least one must have the candidate as first author. Neither may have been used for another specialty board.
Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. The issuer's example is approval in December 2025 permitting 2026-2030 examinations. This is an exam window, not renewal.
The published 2026 administration was remote using ExamSoft, with Phase I on May 19 and Phase II on June 30. Those dates have passed and a 2027 schedule was not verified, so confirm delivery arrangements with the ACVCP before planning travel.